Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Virtual Congress 2020

Checkpoint inhibitors and beyond in gynaecological cancers

Q&A and live discussion

Date

18 Oct 2020

Session

Checkpoint inhibitors and beyond in gynaecological cancers

Topics

Tumour Site

Gynaecological Malignancies

Presenters

Susana Banerjee

Authors

S. Banerjee

Author affiliations

  • Gynaecology Department, Royal Marsden Hospital NHS Foundation Trust, SW3 6JJ - London/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Biomarkers

Presenter: Iain McNeish

Session: Checkpoint inhibitors and beyond in gynaecological cancers

Resources:

Slides

Webcast

Immune therapy combinations

Presenter: Sandro Pignata

Session: Checkpoint inhibitors and beyond in gynaecological cancers

Resources:

Slides

Webcast

T cells and related treatments

Presenter: George Coukos

Session: Checkpoint inhibitors and beyond in gynaecological cancers

Resources:

Slides

Webcast

Antibody Drug Conjugates (ADCs)

Presenter: Susana Banerjee

Session: Checkpoint inhibitors and beyond in gynaecological cancers

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.